APG ASSET MANAGEMENT N.V. – Regeneron Pharmaceuticals, Inc. Transaction History
APG ASSET MANAGEMENT N.V. portfolio value:
$111.51M
portfolio value
APG ASSET MANAGEMENT N.V. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -36.89% | -92.71K shares | -30.57M | $688.87 | 158.59K |
Q2 2022 | share | Decrease | -32.91% | -123.28K shares | -93.04M | $591.13 | 251.30K |
Q1 2022 | share | Decrease | -8.10% | -33.02K shares | 8.77M | $698.42 | 374.59K |
Q4 2021 | share | Decrease | -1.97% | -8.2K shares | 9.23M | $642.51 | 407.62K |
Q3 2021 | share | Decrease | -1.93% | -8.2K shares | 17.42M | $605.18 | 415.82K |
Q2 2021 | share | Decrease | -0.21% | -877 shares | 28.65M | $558.54 | 424.02K |
Q1 2021 | share | Decrease | -6.92% | -31.56K shares | -9.18M | $473.14 | 424.90K |
Q4 2020 | share | Increase | +33.96% | 115.71K shares | 17.56M | $483.11 | 456.46K |
Q3 2020 | share | Increase | +7.75% | 24.5K shares | -12.94M | $559.78 | 340.75K |
Q2 2020 | share | Increase | +510.69% | 264.47K shares | 150.32M | $623.65 | 316.25K |
Q1 2020 | share | Increase | +70.30% | 21.37K shares | 15.11M | $488.29 | 51.78K |
Q4 2019 | share | Increase | +24.33% | 5.95K shares | 3.94M | $375.48 | 30.41K |
Q3 2019 | share | Decrease | -83.63% | -124.92K shares | -34.83M | $277.4 | 24.46K |
Q2 2019 | share | Increase | +0.07% | 100 shares | -13.53M | $313 | 149.38K |
Q1 2019 | share | Increase | +712.11% | 130.9K shares | 48.58M | $410.62 | 149.28K |
Q4 2018 | share | Decrease | -1.08% | -200 shares | -458K | $373.5 | 18.38K |
Q3 2018 | share | 0.00% | 0 shares | 973K | $404.04 | 18.58K | |
Q2 2018 | share | 0.00% | 0 shares | 288K | $344.99 | 18.58K | |
Q1 2018 | share | 0.00% | 0 shares | -615K | $344.36 | 18.58K | |
Q4 2017 | share | Decrease | -11.33% | -2.37K shares | -3.55M | $375.96 | 18.58K |
Q3 2017 | share | Increase | +11.14% | 2.1K shares | 109K | $447.12 | 20.95K |
Q2 2017 | share | Decrease | -62.69% | -31.69K shares | -10.32M | $491.14 | 18.85K |
Q1 2017 | share | Decrease | -38.92% | -32.21K shares | -9.21M | $387.51 | 50.54K |
Q4 2016 | share | Decrease | -14.11% | -13.6K shares | -9.93M | $367.09 | 82.75K |
Q3 2016 | share | Decrease | -0.31% | -300 shares | 4.98M | $402.02 | 96.35K |
Q2 2016 | share | Increase | +12.32% | 10.6K shares | 2.73M | $349.23 | 96.65K |
Q1 2016 | share | Increase | +15.37% | 11.46K shares | -9.47M | $360.44 | 86.05K |